 Adrenal Gland Neoplasms
"Adrenal Gland Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the ADRENAL GLANDS.
| Descriptor ID |
D000310
|
| MeSH Number(s) |
C04.588.322.078 C19.053.347 C19.344.078
|
| Concept/Terms |
Adrenal Gland Neoplasms- Adrenal Gland Neoplasms
- Adrenal Gland Neoplasm
- Neoplasm, Adrenal Gland
- Adrenal Neoplasm
- Adrenal Neoplasms
- Neoplasm, Adrenal
- Neoplasms, Adrenal
- Neoplasms, Adrenal Gland
Adrenal Cancer- Adrenal Cancer
- Adrenal Cancers
- Cancer, Adrenal
- Cancers, Adrenal
- Cancer of the Adrenal Gland
- Adrenal Gland Cancer
- Adrenal Gland Cancers
- Cancer, Adrenal Gland
- Cancers, Adrenal Gland
|
Below are MeSH descriptors whose meaning is more general than "Adrenal Gland Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Adrenal Gland Neoplasms".
This graph shows the total number of publications written about "Adrenal Gland Neoplasms" by people in this website by year, and whether "Adrenal Gland Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 1998 | 0 | 1 | 1 | | 2000 | 2 | 0 | 2 | | 2001 | 1 | 0 | 1 | | 2006 | 2 | 0 | 2 | | 2007 | 1 | 1 | 2 | | 2008 | 2 | 0 | 2 | | 2009 | 1 | 0 | 1 | | 2010 | 0 | 1 | 1 | | 2011 | 0 | 1 | 1 | | 2012 | 4 | 0 | 4 | | 2013 | 4 | 0 | 4 | | 2014 | 0 | 1 | 1 | | 2015 | 4 | 0 | 4 | | 2016 | 1 | 1 | 2 | | 2017 | 2 | 1 | 3 | | 2018 | 3 | 1 | 4 | | 2019 | 4 | 1 | 5 | | 2020 | 3 | 0 | 3 | | 2021 | 5 | 1 | 6 | | 2022 | 5 | 0 | 5 | | 2023 | 5 | 0 | 5 | | 2024 | 1 | 0 | 1 | | 2025 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenal Gland Neoplasms" by people in Profiles.
-
Rednam SP, Kamihara J, Becktell KD, Brodeur GM, States LJ, Voss SD, Villani A, Zelley K, Malkin D, Nakano Y, Doria AS, Widjaja E, Pajtler KW, Schneider KW, Achatz MI, Diller LR, Gallinger B, Tamura C, Wasserman JD. Update on Tumor Surveillance for Children with Hereditary Pheochromocytoma/Paraganglioma Syndromes. Clin Cancer Res. 2025 Aug 14; 31(16):3368-3376.
-
Balderrama-Brondani V, Al-Ward R, Kiseljak-Vassiliades K, Fishbein L, Dawes D, Hamidi O, Pishdad R, Perdomo Rodriguez JP, Sukkari MA, Grajo JR, Ghayee HK, Bedrose S, Bassett RL, Hamrahian AH, Habra MA. Clinical and Radiological Features of Atypical Adrenal Masses-A Multicenter Retrospective Study. J Clin Endocrinol Metab. 2025 Jun 17; 110(7):e2183-e2190.
-
Meir M, Wiegering A, Sperschneider F, Hendricks A, Lock JF, Flemming S, Kelm M, Hahner S, Schlegel N, Germer CT, Reibetanz J. Laparoscopic vs. Robotic transabdominal adrenalectomy- propensity matched analysis and learning curve. Langenbecks Arch Surg. 2025 Mar 27; 410(1):108.
-
Flynn A, Pattison AD, Balachander S, Boehm E, Bowen B, Dwight T, Rossello FJ, Hofmann O, Martelotto L, Zethoven M, Kirschner LS, Else T, Fishbein L, Gill AJ, Tischler AS, Giordano T, Prodanov T, Noble JR, Reddel RR, Trainer AH, Ghayee HK, Bourdeau I, Elston M, Ishak D, Ngeow Yuen Yie J, Hicks RJ, Crona J, ?kerstr?m T, St?lberg P, Dahia P, Grimmond S, Clifton-Bligh R, Pacak K, Tothill RW. Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles. Nat Commun. 2025 Mar 17; 16(1):2632.
-
Wolf KI, Rose-Krasnor L, Alband S, Lenders JWM, Fishbein L. Patient-reported burden associated with pheochromocytoma/paraganglioma diagnosis. Endocr Relat Cancer. 2024 Jun 01; 31(6).
-
Chatzikyriakou P, Brempou D, Quinn M, Fishbein L, Noberini R, Anastopoulos IN, Tufton N, Lim ES, Obholzer R, Hubbard JG, Moonim M, Bonaldi T, Nathanson KL, Izatt L, Oakey RJ. A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide. Clin Epigenetics. 2023 12 20; 15(1):196.
-
Sharma S, Fishbein L. Diagnosis and Management of Pheochromocytomas and Paragangliomas: A Guide for the Clinician. Endocr Pract. 2023 Dec; 29(12):999-1006.
-
Townsel A, Henry CJ. Sex, aging, immunity and adrenal cancer. Nat Aging. 2023 07; 3(7):764-765.
-
Taïeb D, Wanna GB, Ahmad M, Lussey-Lepoutre C, Perrier ND, Nölting S, Amar L, Timmers HJLM, Schwam ZG, Estrera AL, Lim M, Pollom EL, Vitzthum L, Bourdeau I, Casey RT, Castinetti F, Clifton-Bligh R, Corssmit EPM, de Krijger RR, Del Rivero J, Eisenhofer G, Ghayee HK, Gimenez-Roqueplo AP, Grossman A, Imperiale A, Jansen JC, Jha A, Kerstens MN, Kunst HPM, Liu JK, Maher ER, Marchioni D, Mercado-Asis LB, Mete O, Naruse M, Nilubol N, Pandit-Taskar N, Sebag F, Tanabe A, Widimsky J, Meuter L, Lenders JWM, Pacak K. Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants. Lancet Diabetes Endocrinol. 2023 05; 11(5):345-361.
-
Jimenez C, Chin BB, Noto RB, Dillon JS, Solnes L, Stambler N, DiPippo VA, Pryma DA. Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma. Endocr Relat Cancer. 2023 02 01; 30(2).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|